Exousia Bio, Inc. (LMMY): key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2024)
- $3.8K
- Net Income/Loss (FY2024)
- $51.4K
- Total Assets (FY2024)
- $0
- Total Equity (FY2024)
- $0
- Cash Flows from Operating Activities (FY2024)
- -$4.5K
Source: Exousia Bio, Inc. 10-K filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
